Physician profile
Thomas Fliedner
NPI 1922016013
$1,392.67
in general payments reported to CMS, 2019-2025
22 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $32.01 · 2021: $327 · 2022: $239 · 2023: $331 · 2024: $144 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $675.78 | 2019-2023 | |
| Pfizer INC. | $114.11 | 2020-2023 | |
| Biogen, INC. | $72.34 | 2024-2025 | Vumerity, Zurzuvae |
| Sumitomo Pharma America, INC. | $69.98 | 2023 | Myfembree |
| Coopersurgical, INC. | $51.14 | 2019-2022 | |
| Exeltis, USA INC. | $45.35 | 2023-2025 | Slynd |
| Sage Therapeutics, LLC | $34.48 | 2025 | |
| Mayne Pharma Commercial LLC | $33.24 | 2024 | |
| Minerva Surgical, INC | $31.44 | 2022-2025 | |
| Ethicon US, LLC | $31.18 | 2019-2025 | Dermabond, Stratafix |
| Astellas Pharma US INC | $29.11 | 2023-2024 | Veozah |
| Hologic Sales and Service, LLC | $27.38 | 2022-2024 | Acessa Provu System |
| Aspira Women'S Health INC | $23.62 | 2022-2023 | Ova1 |
| Medtronic, INC. | $22.76 | 2025 | Ligasure |
| Novo Nordisk INC | $22.16 | 2024 | Wegovy |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $20.81 | 2021 | |
| Mylan Pharmaceuticals INC. | $19.04 | 2022 | |
| Vivus LLC | $17.05 | 2019 | |
| Millicent US INC | $15.42 | 2023 | Intrarosa |
| Avion Pharmaceuticals | $12.99 | 2023 | Balcoltra |
| Ascend Therapeutics US, LLC | $12.22 | 2021 | |
| Allergan, INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Fliedner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.